Total Funding
77
51
Total FundingGrant raised
Growth Score
-11 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
82751
Avextra is a pharmaceutical manufacturing industry.
Ana Maria Serrato Navas: Head Drug Development / Business Development Emerging MarketsPast Role: Aegerion Pharmaceuticals, Country Manager, Colombia
About the Company
Avextra is a pharmaceutical company that also offers manufacturing services for cannabis products. Their solutions provide medical professionals, patients, and communities with secure, standardized therapeutic options. By practicing plant-based medicine, they want to maximize this old medicinal plant's therapeutic potential for the benefit of
patients all around the world.
